PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jcdrAbout UsAuthor ServicesArchiveSubmitJCDR
 
J Clin Diagn Res. 2017 January; 11(1): ZC122–ZC124.
Published online 2017 January 1. doi:  10.7860/JCDR/2017/24654.9309
PMCID: PMC5324486

Comparative Analysis of Salivary Alkaline Phosphatase in Post menopausal Women with and without Periodontitis

Abstract

Introduction

Alkaline phosphatase is an intracellular destruction enzyme in the periodontium, and it takes part in the normal turnover of the periodontal ligament, alveolar bone, and root cementum formation and maintenance.

Aim

The aim of this case control study was to evaluate the enzyme Alkaline Phosphatase (ALP) level in saliva of post menopausal women with and without chronic periodontitis.

Materials and Methods

In this study, 40 individuals, satisfying the study inclusion and exclusion criteria, were recruited. They were categorically divided, on the basis of gingival index, probing pocket depth and clinical attachment level, into two groups: Group I (post menopausal women with a clinically healthy periodontium, n=20); and Group II (post menopausal women with generalized chronic periodontitis, n=20). Clinical parameters assessed were Plaque Index (PI), Gingival Index (GI), Clinical Attachment Level (CAL) and Probing Pocket Depth (PPD). Unstimulated salivary samples were obtained in which the ALP concentration was measured using p-Nitrophenylphosphate, and 2-amino-2-methyl-1-propanol reagents in Beckman and Coulter, AU 480 auto analyser. Mann-Whitney U test was used to find statistical difference with respect to all clinical parameters such as PI, GI, CAL, PPD and salivary ALP levels.

Results

The mean ALP in saliva was found to be higher in Group II compared to Group I and the difference was statistically significant with the p-value of 0.008.

Conclusion

A noteworthy increase in the ALP concentration was seen in saliva in our study (Group II) may be due to increased periodontal inflammation in post menopausal women. Thus salivary ALP can be taken as an additional biomarker to early diagnosis, development and progression of periodontitis especially among post menopausal women.

Keywords: Alveolar bone loss, Biomarker, Menopause, Oestrogen, Saliva

Introduction

Periodontitis is inflammation of the periodontium that extends beyond the gingiva and produces destruction of connective tissue attachment of teeth [1]. In periodontal disease, the balance between synthesis and degradation is disrupted and the collagen fibrils of periodontal ligament are broken down together with the supporting alveolar bone. Different enzymes involved in both the intracellular and the extracellular pathway of tissue destruction have been investigated as potential diagnostic markers of periodontitis [2]. Among the intracellular destruction enzymes that have received the most attention as possible marker of active periodontal destruction is ALP. This enzyme is released from dead and dying cells of the periodontium, mostly from polymorpho-nuclear leukocytes. ALP is a membrane bound enzyme, which hydrolyzes monophosphate ester bonds and increases the local concentration of phosphate ions. ALP is a very important enzyme in the periodontium, as it takes part in the normal turnover of the periodontal ligament and alveolar bone and root cementum formation and maintenance. ALP is produced by many cells like neutrophils, fibroblasts, osteoblasts and osteoclasts. Few longitudinal studies reported higher Gingival Crevicular Fluid (GCF) ALP levels in active periodontal disease sites [35].

In women, menopause is associated with oestrogen deficient state. In menopause, the balance between bone formation and bone resorption is altered, resulting in excessive bone resorption. Bhattarai T et al., also reported higher serum ALP levels in post menopausal women [6]. Reduced oestrogen leads to alveolar bone resorption, clinical attachment loss and tooth loss [7]. Oestrogen deficiency is considered as a risk indicator for periodontal disease. ALP levels in saliva and GCF are considered as a potential diagnostic marker for periodontitis [8]. Limited studies are available to address the periodontal disease activity among post menopausal women. It has been hypothesized that post menopausal women are prone for alveolar bone loss and salivary ALP levels are an indicator of periodontal disease. This study was aimed to evaluate the enzyme ALP level in saliva of post menopausal women with and without chronic periodontitis.

Materials and Methods

The present case control study included 40 post menopausal women with age between 45-60 years. The study participants were selected from the outpatient pool of Thaimoogambigai Dental College, Chennai. The study was conducted from January 2016 to May 2016. The ethical clearance was obtained from Dr. MGR University Ethical Committee, Chennai, India. Based on the study of Daltaban O et al., the sample size was estimated to be 20 per group [9]. The protocol was explained and written informed consent was obtained from all the participants. The subjects were screened for periodontal and menopause status and categorized into two groups as 20 post menopausal women and periodontally healthy (Group I) and 20 post menopausal women with generalized chronic periodontitis (Group II).

The participants were enrolled according to inclusion and exclusion criteria. The inclusion criteria for both the groups were that the post menopausal women should be aged between 45-60 years, with minimum number of 20 teeth. Group I subjects had GI score of 0 and Group II subjects had CAL of 3-5 mm in more than 30% of sites. The patients having less than 20 numbers of teeth, patients who had taken anti-inflammatory drugs or antibiotics within previous three months and who underwent periodontal treatment in the past six month were excluded. Clinical parameters assessed were PI, GI, CAL and PPD.

PI was recorded at four sites (mesiobuccal, midbuccal, distobuccal and mid palatal sites) around each tooth [10]. Four gingival areas of the tooth (facial, mesial, distal and lingual) around each tooth were examined according to GI scores given by Loe and Silness [11]. Subjects with healthy periodontium had GI score of 0. The selection criteria for generalized chronic periodontitis were patients having 3-5 mm of CAL in more than 30% of the sites [12]. The CAL was recorded using a William’s graduated periodontal probe at six sites per tooth and measured in millimetres. CAL was measured as the distance from the cemento-enamel junction to the bottom of the periodontal pocket. Periodontal Probing was performed at six sites per tooth (mesiobuccal, distobuccal, mesiolingual, distolingual, midbuccal, midlingual).

Estimation of ALP: A 10 ml of unstimulated saliva sample was collected and centrifuged at 500 rpm. Using Beckman and Coulter, AU 480 auto analyser, ALP was estimated and the value of ALP was expressed in U/L. The reagents used were p-Nitrophenylphospate, and 2-amino-2-methyl-1-propanol. The salivary ALP levels were found to be 20.70±7.18 U/L in healthy periodontium, 33.06±5.49 U/L in gingivitis and 49.62±16.46 U/L in Periodontitis in the study conducted by Patel RM [13]. Mann-Whitney U test was used to find statistical differences with respect to clinical parameters like PI, GI, PPD, CAL, salivary ALP levels.

Results

The mean scores of periodontal parameters like PI, GI, PPD, CAL of group I and group II has been mentioned in [Table/Fig-1] and difference was statistically significant with p-value of 0.008. The mean salivary ALP level was found to be higher in group II compared to group I and difference was statistically significant with p-value of 0.008 [Table/Fig-1].

[Table/Fig-1]
Mann-Whitney U Test for comparison of clinical parameters between the two groups.

Discussion

Conventional diagnostic techniques like clinical and radiographic methods do not determine the present activity of the periodontal disease [14]. The biochemical methods for periodontal diagnosis use saliva and GCF samples. GCF collection is cumbersome and complicated. Saliva is the diagnostic fluid of choice in the 21st century. Saliva can be collected easily and may contain both locally and systemically derived markers of periodontal disease, which can be evaluated for diagnostic purposes. The use of saliva as biomarker has been the subject of considerable research activity in periodontal diagnosis [15,16].

Menopause is termed as permanent cessation of menses that occurs naturally or is induced by surgery resulting from reduced ovarian hormone secretion. Both aging and menopause are associated with accelerated bone mass loss. Bone turnover rate is higher in alveolar bone compared to long bones. Therefore, the systemic imbalance in bone resorption and deposition might be manifested initially in the alveolar process than in other sites [17]. The possible mechanism by which post menopausal women lead to more periodontal destruction may be the presence of less crestal alveolar bone per unit volume, this bone of lesser density may be more easily resorbed. Oestrogen acts by blocking the production of cytokines that promote osteoclast differentiation and osteoclast apoptosis [18]. Oestrogen withdrawal following menopause is associated with increased osteoclast numbers due to enhanced osteoclast formation activity and reduced osteoclast apoptosis [19]. ALP is associated with osteoid formation and mineralization. ALP enzyme is considered as a potential marker of alveolar bone resorption in post menopausal women [20]. Our study was carried out to evaluate the enzyme ALP level in saliva of post menopausal women with and without chronic periodontitis.

On comparison of clinical parameters like PI, GI, PPD and CAL, group II had higher mean scores compared to group I, which is similar to the study by Amitha et al., [20].

The present study results showed an increase in salivary ALP levels in post menopausal women with chronic periodontitis compared to post menopausal women with healthy periodontium which is comparable to previous studies [21,22]. The presence of high levels of ALP in saliva in post menopausal women with periodontitis may be due to increased periodontal inflammation and rapid bone turnover rates as ALP is produced not only by the cells of the periodontium, but secreted mostly by neutrophils and bacterial sources present in supra and sub gingival plaque. ALP is normally stored in specific granules of neutrophils and is released on migration to the site of periodontal infection. As this enzyme is associated with periodontal inflammation, ALP levels can also be used as an indicator of efficacy of periodontal therapy [23].

The salivary ALP level in periodontally healthy subject was found to be 20.70±7.18 U/L in a previous study [13] but in our study, Group I subjects had slightly higher mean salivary ALP levels compared to mean ALP levels of periodontally healthy subjects in the previous study, in spite of minimal inflammatory status in the periodontal tissues. Bhattarai T et al., and Ramesh A et al., also reported higher serum ALP levels in post menopausal women [6,20]. Since salivary ALP is associated with altered bone metabolism, it clearly shows that in post menopausal women, the balance between bone formation and resorption is lost and hence they are susceptible to alveolar bone resorption, CAL and tooth loss. Since salivary ALP levels are an early indicator of periodontal disease, prompt attempt can be carried out in the form of periodontal therapy or systemic therapy to arrest the progression of periodontal disease in post menopausal women. This post menopausal women cohort represents a large number of patients that present in clinical practices. Therefore dental clinicians must be aware of the effects of reduced hormones on the periodontal tissues and can take steps to prevent periodontal disease progression. Further longitudinal interventional trials are needed to confirm this association.

Limitation

Our study is an observational study with small sample size and has proved the use of salivary ALP levels as a periodontal disease marker in post menopausal women. Further longitudinal studies involving more participants from similar population with intervention trials can overcome these limitations.

Conclusion

ALP level is increased in post menopausal women with chronic periodontitis than in postmenopausal women with healthy periodontium. In our study, ALP was found to be high in both the groups. Post menopausal women are more prone to periodontal infections therefore they should be motivated to maintain proper oral hygiene. Hence salivary ALP can be taken as an additional biomarker to early diagnosis of development and progression of periodontitis especially among post menopausal women.

Notes

Financial or Other Competing Interests

None.

References

[1] Ranney RR. Classification of periodontal diseases. Periodontol 2000. 1993;2:13–25. [PubMed]
[2] Kinane DF. Regulation of tissue destruction and homeostasis as diagnostic aids in periodontology. Periodontol 2000. 2000;24:215–25. [PubMed]
[3] Nakamura M, Slots J. Salivary enzymes: Origin and relationship to periodontal disease. J Periodontal Res. 1983;18:559–69. [PubMed]
[4] Ishikawa I, Cimasoni G. Alkaline phosphatase in human gingival fluid and its relation to periodontitis. Arch Oral Biol. 1970;15:1401–04. [PubMed]
[5] Binder TA, Goodson JM, Socransky SS. Gingival fluid levels of acid and alkaline Phosphatase. J Periodontal Res. 1987;22:14–19. [PubMed]
[6] Bhattarai T, Bhattacharya K, Chaudhuri P, Sengupta P. Correlation of common biochemical markers for bone turnover, serum calcium, and alkaline phosphatase in post-menopausal women. Malays J Med Sci. 2014;21:58–61. [PMC free article] [PubMed]
[7] Kribbs PJ. Comparison of mandibular bone in normal and osteoporotic women. J Prosthet Dent. 1990;63:218–22. [PubMed]
[8] Bezerra AA, Pallos D, Cortelli JR, Saraceni CH, Queiroz C. Evaluation of organic and inorganic compounds in the saliva of patients with chronic periodontal disease. Rev Odonto Cienc. 2010;25:234–38.
[9] Daltaban O, Saygun I, Bal B, Balos K, Serdar M. Gingival crevicular fluid alkaline phosphatase levels in postmenopausal women: Effects of phase I periodontal treatment. J Periodontol. 2006;77:67–72. [PubMed]
[10] Silness J, Loe H. Periodontal disease in pregnancy II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand. 1964;22:112–35. [PubMed]
[11] Löe H. The gingival index, the plaque index and the retention index systems. J Periodontol. 1967;38:610. [PubMed]
[12] Armitage GC. Development of a classification system for periodontal disease and conditions. Ann Periodontol. 1999;4:1–6. [PubMed]
[13] Patel RM, Varma S, Suragimath G, Zope S. Estimation and comparison of salivary calcium, phosphorus, alkaline phosphatase and pH levels in periodontal health and disease: A cross-sectional biochemical study. Journal of Clinical and Diagnostic Research. 2016;10(7):ZC58–ZC61. [PMC free article] [PubMed]
[14] Zappa U. Histology of the periodontal lesion: Implications for diagnosis. Periodontol 2000. 1995;7:22–38. [PubMed]
[15] Malamud D, Tabak LA, editors. Saliva as a Diagnostic Fluid. Ann NY Acad Sci. 1992 Malamud D, Tabak LA, eds. Saliva as a Diagnostic Fluid; No. 694.
[16] Ng PY, Donley M, Hausmann E, Hutson AD, Rossomando EF, Scannapieco FA. Candidate salivary biomarkers associated with alveolar bone loss: Cross sectional and in-vitro studies. Immunol Med Microbiol. 2007;49:252–60. [PMC free article] [PubMed]
[17] Matsuura T, Tokutomi K, Sasaki M, Katafuchi M, Mizumachi E, Sato H. Distinct characteristics of mandibular bone collagen relative to long bone collagen: Relevance to clinical dentistry. BioMed Research International 2014. 2014 769414. [PMC free article] [PubMed]
[18] Pacifini R. Is there a causal role of IL-1 in postmenopausal bone loss? Calcif Tissue Int. 1992;50:295–99. [PubMed]
[19] Tezal M, Wactawski-Wende J, Grossi SG, Ho AW, Dunford R, Genco RJ. The relationship between bone mineral density and periodontitis in post-menopausal women. J Periodontol. 2000;71:1492–98. [PubMed]
[20] Ramesh A, Bhandary R, Thomas B, Souza SRD, Kumari S. Alkaline phosphatase – A diagnostic marker of periodontitis in postmenopausal women – A biochemical study. Nitte University Journal of Health Science. 2013;3:71–73.
[21] Malhotra R, Grover V, Kapoor A, Kapur R. Alkaline phosphatase as a periodontal disease marker. Indian J Dent Res. 2010;21:531–36. [PubMed]
[22] Dabra S, Singh P. Evaluating the levels of salivary alkaline and acid phosphatase activities as biochemical markers for periodontal disease: A case series. Dent Res J. 2012;9:41–45. [PMC free article] [PubMed]
[23] Van Lente F. Alkaline and acid phosphatase determinations in bone disease. Orthop Clin North Am. 1979;10:437–50. [PubMed]

Articles from Journal of Clinical and Diagnostic Research : JCDR are provided here courtesy of JCDR Research & Publications Private Limited